Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2
Phase of Trial: Phase IV
Latest Information Update: 21 Nov 2016
At a glance
- Drugs Liraglutide (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 18 Jan 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 29 Jan 2014 Status changed from recruiting to active, no longer recruiting, ClinicalTrials.gov record.
- 09 Sep 2013 Planned end date changed from 1 Sep 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov.